Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Urology
Volume 2015 (2015), Article ID 646875, 4 pages
Case Report

Management of Metachronous Bilateral Testis Cancer in a Patient with Pre-B Cell ALL

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

Received 24 November 2014; Accepted 27 January 2015

Academic Editor: Apul Goel

Copyright © 2015 Kelly T. Harris et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


We present a patient with a metachronous, second testicular cancer after being diagnosed with pre-B cell ALL and receiving induction chemotherapy for a bone marrow transplant. We discuss the management of bilateral testis masses in a young patient with a hematologic malignancy as well as the role of immunosuppressive chemotherapy in developing a second cancer. This case illustrates the importance of recognizing bilateral testicular cancer early, as well as the importance of follow-up care in oncology patients including routine measurements of tumor markers. A multidisciplinary approach between medical oncology and urology, including close monitoring of the contralateral testis, remains paramount to patient care.